Creative Biolabs offers integrated, non-human primate (NHP)-based research solutions to support your preclinical development programs with precision and reliability. Leveraging our deep expertise in NHP biologicals, validated models, and stringent quality systems, we enable scientists and drug developers to generate robust, clinically translatable data across multiple therapeutic areas.

Our comprehensive service offerings include:

NHP In Vivo Pharmacokinetic Study Service

NHP based Pharmacology and Pharmacodynamic Service

NHP Biospecimen Custom Collection Service

NHP based Gene Therapeutic Development Service

In addition to the services above, we also offer:

• Safety Assessments: Detailed evaluation of immune responses and toxicity to support IND-enabling studies.
• Biodistribution Studies: Comprehensive tracking of therapeutic distribution across tissues using NHP models.
• Regulatory-Compliant Study Design: Custom protocols tailored to GLP/GCP standards and submission requirements.
• Scientific Consultation and Project Management: Expert guidance from study planning through data reporting.
• NHP-based Safety Profile Evaluation: Comprehensive evaluation of therapeutic safety profiles in NHP models, including toxicology, immunotoxicity, and tolerability studies.
• Method Development & Validation: Custom assay design and rigorous validation for pharmacokinetics, immunogenicity, or biomarker readouts, supporting regulatory submissions and scientific reproducibility.
• Biomarker Discovery & Validation: Identification and qualification of predictive or mechanistic biomarkers using NHP biospecimens and multi-omics approaches to enhance translational insight.

Why Choose Us:

• Access to well-characterized cynomolgus and rhesus macaques from accredited colonies
• Scientific guidance from NHP specialists with decades of experience
• End-to-end project management from protocol development to data delivery
• Rigid adherence to animal welfare standards and global regulatory expectations

We help bridge your early discovery efforts with clinical success—through dependable NHP platforms, actionable data, and collaborative support.